These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles. Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671 [TBL] [Abstract][Full Text] [Related]
44. Saliva as a non-invasive specimen for COPD assessment. Melo-Dias S; Valente C; Andrade L; Marques A; Sousa A Respir Res; 2022 Jan; 23(1):16. PubMed ID: 35093093 [TBL] [Abstract][Full Text] [Related]
45. Symptom-related sputum microbiota in stable chronic obstructive pulmonary disease. Diao W; Shen N; Du Y; Erb-Downward JR; Sun X; Guo C; Ke Q; Huffnagle GB; Gyetko MR; He B Int J Chron Obstruct Pulmon Dis; 2018; 13():2289-2299. PubMed ID: 30104869 [TBL] [Abstract][Full Text] [Related]
46. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Millares L; Ferrari R; Gallego M; Garcia-Nuñez M; Pérez-Brocal V; Espasa M; Pomares X; Monton C; Moya A; Monsó E Eur J Clin Microbiol Infect Dis; 2014 Jul; 33(7):1101-11. PubMed ID: 24449346 [TBL] [Abstract][Full Text] [Related]
47. Analysis of the lung microbiome in the "healthy" smoker and in COPD. Erb-Downward JR; Thompson DL; Han MK; Freeman CM; McCloskey L; Schmidt LA; Young VB; Toews GB; Curtis JL; Sundaram B; Martinez FJ; Huffnagle GB PLoS One; 2011 Feb; 6(2):e16384. PubMed ID: 21364979 [TBL] [Abstract][Full Text] [Related]
48. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease. Garcia-Nuñez M; Millares L; Pomares X; Ferrari R; Pérez-Brocal V; Gallego M; Espasa M; Moya A; Monsó E J Clin Microbiol; 2014 Dec; 52(12):4217-23. PubMed ID: 25253795 [TBL] [Abstract][Full Text] [Related]
49. Analysis of microbiota in stable patients with chronic obstructive pulmonary disease. Aguirre E; Galiana A; Mira A; Guardiola R; Sánchez-Guillén L; Garcia-Pachon E; Santibañez M; Royo G; Rodríguez JC APMIS; 2015 May; 123(5):427-32. PubMed ID: 25858184 [TBL] [Abstract][Full Text] [Related]
50. Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients. Tangedal S; Aanerud M; Persson LJ; Brokstad KA; Bakke PS; Eagan TM Respir Res; 2014 Nov; 15(1):138. PubMed ID: 25398249 [TBL] [Abstract][Full Text] [Related]
51. Exacerbation induces a microbiota shift in sputa of COPD patients. Jubinville E; Veillette M; Milot J; Maltais F; Comeau AM; Levesque RC; Duchaine C PLoS One; 2018; 13(3):e0194355. PubMed ID: 29579057 [TBL] [Abstract][Full Text] [Related]
52. Sputum microbiome profiling in COPD: beyond singular pathogen detection. Ditz B; Christenson S; Rossen J; Brightling C; Kerstjens HAM; van den Berge M; Faiz A Thorax; 2020 Apr; 75(4):338-344. PubMed ID: 31996401 [TBL] [Abstract][Full Text] [Related]
53. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Molyneaux PL; Mallia P; Cox MJ; Footitt J; Willis-Owen SA; Homola D; Trujillo-Torralbo MB; Elkin S; Kon OM; Cookson WO; Moffatt MF; Johnston SL Am J Respir Crit Care Med; 2013 Nov; 188(10):1224-31. PubMed ID: 23992479 [TBL] [Abstract][Full Text] [Related]
54. Resistome analyses of sputum from COPD and healthy subjects reveals bacterial load-related prevalence of target genes. Ramsheh MY; Haldar K; Bafadhel M; George L; Free RC; John C; Reeve NF; Ziegler-Heitbrock L; Gut I; Singh D; Mistry V; Tobin MD; Oggioni MR; Brightling C; Barer MR Thorax; 2020 Jan; 75(1):8-16. PubMed ID: 31699806 [TBL] [Abstract][Full Text] [Related]
55. The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study. Chen YF; Hou HH; Chien N; Lu KZ; Lin CH; Liao YC; Lor KL; Chien JY; Chen CM; Chen CY; Cheng SL; Wang HC; Hsueh PR; Yu CJ Respir Res; 2024 Aug; 25(1):308. PubMed ID: 39143556 [TBL] [Abstract][Full Text] [Related]
56. Impact of prophylactic and 'rescue pack' antibiotics on the airway microbiome in chronic lung disease. Rofael SAD; Brown J; Lipman MCI; Lowe DM; Spratt D; Quaderi S; Hurst JR; McHugh TD BMJ Open Respir Res; 2023 Apr; 10(1):. PubMed ID: 37085283 [TBL] [Abstract][Full Text] [Related]
57. Characterization of throat microbial flora in smokers with or without COPD. Diao W; Shen N; Du Y; Qian K; He B Int J Chron Obstruct Pulmon Dis; 2017; 12():1933-1946. PubMed ID: 28740374 [TBL] [Abstract][Full Text] [Related]
58. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782 [TBL] [Abstract][Full Text] [Related]
59. The airway microbiome in COPD, bronchiectasis and bronchiectasis-COPD overlap. Tiew PY; Jaggi TK; Chan LLY; Chotirmall SH Clin Respir J; 2021 Feb; 15(2):123-133. PubMed ID: 33063421 [TBL] [Abstract][Full Text] [Related]
60. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study. Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]